JPRN-UMIN000009712
Completed
未知
Study on the safety and efficacy of the treatment of polidocanol injection for vascular lesions in the small bowel. - Study on the safety and efficacy of polidocanol injection
niversity of Tokyo0 sites20 target enrollmentJanuary 7, 2013
ConditionsVascular lesions in the small bowel
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Vascular lesions in the small bowel
- Sponsor
- niversity of Tokyo
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with intestinal perforation 2\. Patients with bleeding tendency 3\. Patients administering anti conaglant drugs 4\. Patients with severe hepatic diseases 5\. Patients with severe renal diseases 6\. Patients with severe respiratory diseases 7\. Patients with severe cardiac diseases 8\. Pregnant or feeding women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 18.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858Therapeutic area: Not possible to specifyEUCTR2014-001815-38-DEAllergan Limited750
Active, not recruiting
Phase 1
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown LinesFacial Rhytides (Forehead Lines, Glabellar Lines)MedDRA version: 18.1Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858Therapeutic area: Not possible to specifyEUCTR2014-001860-36-IEAllergan Limited400
Active, not recruiting
Phase 1
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 17.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001815-38-BEAllergan Limited750
Active, not recruiting
Phase 1
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 18.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858Therapeutic area: Not possible to specifyEUCTR2014-001815-38-GBAllergan Limited750
Active, not recruiting
Not Applicable
Study on the effectiveness and safety of the treatment of hyponatremia due to inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients affected by pituitary disorders.EUCTR2012-004071-39-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO